They'll be heading to Phoenix with their families for a few days to meet players, participate in warmups, tour the clubhouse ...
They'll be heading to Phoenix with their families for a few days to meet players, participate in warmups, tour the clubhouse and throw out the first pitch at a spring training game.
of andecaliximab in patients with fibrodysplasia ossificans progressiva (FOP). The dosing milestone for andecaliximab, āshibio’s lead product candidate, marks advancement of the company’s first ...
as well as for the treatment of fibrodysplasia ossificans progressiva. Keros' third product candidate, KER-012, is being developed for the treatment of disorders associated with bone loss ...
In a mouse model of fibrodysplasia ossificans progressiva (FOP)-a genetic condition causing abnormal bone growth in soft tissues-DDR2 deficiency markedly reduced heterotopic ossification.